Compare CVS Health Corp (CVS) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Zillow Group Inc Class C — how do they compare? CVS Health Corp trades at $103.93 (market cap $135.48B), while Zillow Group Inc Class C trades at $31.67 (market cap $7.28B). The key difference: CVS Health Corp is far larger — about 18.6× Zillow Group Inc Class C's market cap, and CVS Health Corp pays a 2.51% dividend while Zillow Group Inc Class C pays none. Which is the better fit depends on your goals.
| CVS | Z | |
|---|---|---|
Market Cap | $135.48B | $7.28B |
Sector | Health | Media |
52-Week High | $106.18 | $90.35 |
52-Week Low | $58.75 | $29.41 |
Enterprise Value | $202.02B | $6.93B |
Dividend Yield | 2.51% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Zillow Group Inc. (Z) trades at $32.19 with no daily change, reflecting a bearish technical signal amid ongoing class action lawsuits. The company shows improving fundamentals with revenue growth from $2.2B in 2024 to $2.6B in 2025 and a return to profitability, though net margins remain thin at 2.27%. Valuation ratios are elevated with a P/E of 127.4, while analyst consensus targets $57.67, implying significant upside if legal and operational risks subside.
The stock presents a high-risk, high-reward scenario. Positive earnings beats and projected margin expansion to 2.26% in 2026 support bullish fundamentals, but legal overhangs and negative cash flow trends pose near-term headwinds. Institutional sentiment is mixed with 46% buy ratings, suggesting cautious optimism contingent on resolution of litigation and execution on growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
